Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-25

Clinical Trial Update: Pramipexole ER vs. Placebo in Fibromyalgia [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing pramipexole extended-release to placebo in fibromyalgia was terminated, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pramipexole ER (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Fibromyalgia | Phase 2 | Status: TERMINATED | Results posted: 2009-11-25